456 related articles for article (PubMed ID: 27696732)
1. Do Short and Sustained Periods of American College of Rheumatology/European League Against Rheumatism Remission Predict Functional and Radiographic Outcome in Early Rheumatoid Arthritis Patients With Low Overall Damage Progression?
Konijn NPC; van Tuyl LHD; Boers M; den Uyl D; Ter Wee MM; Kerstens P; Voskuyl AE; van Schaardenburg D; Nurmohamed MT; Lems WF
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):989-996. PubMed ID: 27696732
[TBL] [Abstract][Full Text] [Related]
2. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
Khawaja MN; Bergman MJ; Yourish J; Pei J; Reiss W; Keystone E
Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
[TBL] [Abstract][Full Text] [Related]
3. Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes.
Paulshus Sundlisæter N; Aga AB; Olsen IC; Hammer HB; Uhlig T; van der Heijde D; Kvien TK; Lillegraven S; Haavardsholm EA;
Ann Rheum Dis; 2018 Oct; 77(10):1421-1425. PubMed ID: 29934373
[TBL] [Abstract][Full Text] [Related]
4. Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome.
van Tuyl LH; Britsemmer K; Wells GA; Smolen JS; Zhang B; Funovits J; van Schaardenburg D; Felson D; Boers M
Ann Rheum Dis; 2012 Jan; 71(1):33-7. PubMed ID: 21953347
[TBL] [Abstract][Full Text] [Related]
5. Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort.
Vermeer M; Kuper HH; Moens HJ; Drossaers-Bakker KW; van der Bijl AE; van Riel PL; van de Laar MA
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1219-26. PubMed ID: 23436821
[TBL] [Abstract][Full Text] [Related]
6. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548
[TBL] [Abstract][Full Text] [Related]
7. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.
Lillegraven S; Prince FH; Shadick NA; Bykerk VP; Lu B; Frits ML; Iannaccone CK; Kvien TK; Haavardsholm EA; Weinblatt ME; Solomon DH
Ann Rheum Dis; 2012 May; 71(5):681-6. PubMed ID: 21994234
[TBL] [Abstract][Full Text] [Related]
8. Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.
Mäkinen H; Kautiainen H; Hannonen P; Möttönen T; Leirisalo-Repo M; Laasonen L; Korpela M; Blåfield H; Hakola M; Sokka T
J Rheumatol; 2007 Feb; 34(2):316-21. PubMed ID: 17183623
[TBL] [Abstract][Full Text] [Related]
9. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
[TBL] [Abstract][Full Text] [Related]
10. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points.
Mack ME; Hsia E; Aletaha D
Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724
[TBL] [Abstract][Full Text] [Related]
11. The impact of patient global assessment in the definition of remission as a predictor of long-term radiographic damage in patients with rheumatoid arthritis: protocol for an individual patient data meta-analysis.
Ferreira RJO; Welsing PMJ; Gossec L; Jacobs JWG; Machado PM; Ndosi M; van der Heijde D; da Silva JAP
Acta Reumatol Port; 2018; 43(1):52-60. PubMed ID: 29602164
[TBL] [Abstract][Full Text] [Related]
12. Do the 2010 ACR/EULAR or ACR 1987 classification criteria predict erosive disease in early arthritis?
Mäkinen H; Kaarela K; Huhtala H; Hannonen PJ; Korpela M; Sokka T
Ann Rheum Dis; 2013 May; 72(5):745-7. PubMed ID: 23172747
[TBL] [Abstract][Full Text] [Related]
13. The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis.
Mueller RB; Schiff M; Kaegi T; Finckh A; Haile SR; Schulze-Koops H; von Kempis J;
Clin Rheumatol; 2015 Jan; 34(1):51-9. PubMed ID: 25024096
[TBL] [Abstract][Full Text] [Related]
14. American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision.
Studenic P; Aletaha D; de Wit M; Stamm TA; Alasti F; Lacaille D; Smolen JS; Felson DT
Ann Rheum Dis; 2023 Jan; 82(1):74-80. PubMed ID: 36280238
[TBL] [Abstract][Full Text] [Related]
15. American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision.
Studenic P; Aletaha D; de Wit M; Stamm TA; Alasti F; Lacaille D; Smolen JS; Felson DT
Arthritis Rheumatol; 2023 Jan; 75(1):15-22. PubMed ID: 36274193
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts.
Britsemmer K; van Schaardenburg D; Boers M; De Cock D; Verschueren P; Radner H; Smolen JS; van Tuyl LHD
Clin Exp Rheumatol; 2018; 36(3):362-370. PubMed ID: 29533752
[TBL] [Abstract][Full Text] [Related]
17. Remission in early rheumatoid arthritis -- a comparison of new ACR/EULAR remission criteria to established criteria.
Kuriya B; Sun Y; Boire G; Haraoui B; Hitchon C; Pope JE; Thorne JC; Keystone EC; Bykerk VP;
J Rheumatol; 2012 Jun; 39(6):1155-8. PubMed ID: 22505708
[TBL] [Abstract][Full Text] [Related]
18. Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice.
Masri KR; Shaver TS; Shahouri SH; Wang S; Anderson JD; Busch RE; Michaud K; Mikuls TR; Caplan L; Wolfe F
J Rheumatol; 2012 Jun; 39(6):1139-45. PubMed ID: 22589262
[TBL] [Abstract][Full Text] [Related]
19. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
[TBL] [Abstract][Full Text] [Related]
20. Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).
Ramiro S; Landewé RB; van der Heijde D; Sepriano A; FitzGerald O; Ostergaard M; Homik J; Elkayam O; Thorne JC; Larche M; Ferraccioli G; Backhaus M; Boire G; Combe B; Schaeverbeke T; Saraux A; Dougados M; Rossini M; Govoni M; Sinigaglia L; Cantagrel AG; Allaart CF; Barnabe C; Bingham CO; Tak PP; van Schaardenburg D; Hammer HB; Dadashova R; Hutchings E; Paschke J; Maksymowych WP
Ann Rheum Dis; 2020 Apr; 79(4):453-459. PubMed ID: 32094157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
